IpiNovyx Bio
Developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Oct 2021.)
Town of Clarkstown New York (HQ)
Authorizing premium user...